Focused Alpha LLC Invests $1.34 Million in CVS Health Corporation $CVS

Focused Alpha LLC acquired a new stake in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, Holdings Channel reports. The firm acquired 12,923 shares of the pharmacy operator’s stock, valued at approximately $1,337,000.

Other hedge funds have also made changes to their positions in the company. Beaird Harris Wealth Management LLC raised its position in CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares during the last quarter. J.Safra Asset Management Corp acquired a new stake in shares of CVS Health in the 2nd quarter valued at approximately $30,000. Dunhill Financial LLC bought a new position in shares of CVS Health during the second quarter worth $32,000. Swiss RE Ltd. bought a new position in CVS Health during the fourth quarter worth about $26,000. Finally, Sankala Group LLC bought a new position in shares of CVS Health during the 4th quarter valued at about $28,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on CVS shares. Truist Financial boosted their price objective on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Wall Street Zen upgraded shares of CVS Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. HSBC reiterated a “hold” rating and issued a $103.00 price objective on shares of CVS Health in a report on Monday, July 6th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $113.00 target price on shares of CVS Health in a report on Monday, June 1st. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $106.75.

CVS Health Stock Performance

Shares of CVS Health stock opened at $93.99 on Tuesday. The firm has a market capitalization of $120.21 billion, a P/E ratio of 24.87, a P/E/G ratio of 0.93 and a beta of 0.61. CVS Health Corporation has a fifty-two week low of $69.40 and a fifty-two week high of $110.68. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The company’s 50 day moving average price is $102.46 and its two-hundred day moving average price is $88.41.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter in the prior year, the firm earned $1.81 EPS. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

Insider Activity at CVS Health

In related news, Director Larry Robbins sold 1,018,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $93.82, for a total value of $95,508,760.00. Following the sale, the director directly owned 5,195,261 shares in the company, valued at $487,419,387.02. This represents a 16.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.85% of the stock is currently owned by corporate insiders.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.